Sunday, December 22, 2024

Variscite & Peridio Team Up to Boost Edge AI Device Development

Related stories

Doc.com Expands AI developments to Revolutionize Healthcare Access

Doc.com, a pioneering healthcare technology company, proudly announces the development...

Amesite Announces AI-Powered NurseMagic™ Growth in Marketing Reach to Key Markets

Amesite Inc., creator of the AI-powered NurseMagic™ app, announces...

Quantiphi Joins AWS Generative AI Partner Innovation Alliance

Quantiphi, an AI-first digital engineering company, has been named...
spot_imgspot_img

Variscite, a leading worldwide System on Module (SoM) designer, developer and manufacturer, announced a partnership with Peridio, an expert in AIoT (Artificial Intelligence of Things) development on the edge. The partnership will support Variscite customers in the development of edge AI/ML applications, enabling the launch of smart solutions while minimizing development challenges and risks.

Peridio offers a comprehensive platform for developing, deploying, and managing edge applications, particularly suited for AIoT development. Variscite customers will have access to the platform which includes Peridio’s development workflows, tools, and features to create and manage edge AI applications. After devices are in the field, Variscite customers can continue to use Perido for secure, bandwidth-optimized OTA updates; to remotely monitor the performance and health of deployed systems; and to schedule rollout strategies to maintain and update AI/ML models and software.

In addition to accelerating time to market, Peridio’s suite eases collaboration among internal team members and provides access to Peridio’s own integration teams, who offer specialized knowledge in developing novel AI-enabled solutions. Peridio’s extensive network of partners in the AI space offers Variscite customers access to additional products, resources, tools, and expertise to create and enhance AI-embedded products.

Peridio’s platform can be used with all Variscite products that have integrated NPU capabilities: DART-MX95, VAR-SOM-MX93, DART-MX93, VAR-SOM-MX8M-PLUS and DART-MX8M-PLUS. These SoMs are pin2pin compatible, divided into two families; DART and VAR-SOM. The Pin2Pin families simplify processor transitions and enhance scalability, providing customers with extended product longevity, faster development, lower costs, and reduced risk.

Also Read: Neuron Launches Dynamic Satellite Capacity Controller

Under the terms of the partnership, Peridio will also provide priority support to Variscite customers.

“The Edge AI market is evolving at a rapid pace, and companies aiming to lead are seeking ways to streamline development while maintaining a competitive edge. Variscite hardware with integrated NPUs lead the SoM market in being AIoT-ready, and our platform adds the ability to quickly implement and manage machine learning-based applications,” said Justin Schneck, Peridio Co-Founder and Chief Product Officer. “This partnership provides an end-to-end solution and ultimately help edge AI companies gain a competitive advantage.”

“Peridio’s platform, workflows, and expertise vastly reduce time-to-market for launching ambitious AIoT applications on Variscite’s i.MX product lines,” said Tal Semo, Managing Director of Sales and Marketing for the Americas. “We are excited to integrate Peridio into Variscite’s technology ecosystem and showcase a joint demo at the upcoming Open Source Summit Europe.”

Peridio has developed a real-time EEG brainwave classification system, illustrating how edge AI can revolutionize healthcare and neuroscience. Its prototype uses research-grade sensors from OpenBCI running on Variscite‘s VAR-SOM-MX93 to instantly analyze brain activity and process complex neurological data at the edge. The system performs advanced visual pattern recognition to identify when a patient’s eyes perceive specific shapes (such as circles or Xs), demonstrating sophisticated real-time visual processing capabilities. The technology is adaptable for various fields, including digital therapeutics, clinical trials, and other neurotechnology applications, showcasing its broad potential in the medical and research sectors.

Source: Businesswire

Subscribe

- Never miss a story with notifications


    Latest stories

    spot_img